Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypoestoxide (PECKO-D) in Parkinson's Disease
NCT04858074Phase 2Completed
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Hypoestoxide in Parkinson's disease (PD). Started Jan 2022; status: completed.
02
Drugs
Hypoestoxide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04858074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04858074.